PMC:7463108 / 111929-112693 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T214 606-609 Disease denotes R21 http://purl.obolibrary.org/obo/MONDO_0015437

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T111 367-376 http://purl.obolibrary.org/obo/OBI_0000245 denotes organized

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T460 390-392 Chemical denotes Co http://purl.obolibrary.org/obo/CHEBI_27638
T80200 412-415 Chemical denotes Lin http://purl.obolibrary.org/obo/CHEBI_32386
T97440 620-622 Chemical denotes MM http://purl.obolibrary.org/obo/CHEBI_53458|http://purl.obolibrary.org/obo/CHEBI_74707
T33787 643-645 Chemical denotes SF http://purl.obolibrary.org/obo/CHEBI_71029

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1391 0-16 Sentence denotes Publisher’s Note
T1392 17-135 Sentence denotes Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
T1393 137-153 Sentence denotes Acknowledgements
T1394 154-389 Sentence denotes Portions of this review were initially presented at the Satellite Symposium of the 25th SNIP Scientific Conference entitled, “Unraveling NeuroAIDS in the Presence of Substance Use Disorder” that was sponsored and organized by NIH/NIDA.
T1395 390-400 Sentence denotes Co-Chairs:
T1396 401-451 Sentence denotes Yu (Woody) Lin and Roger Sorensen (April 10, 2019)
T1397 453-460 Sentence denotes Funding
T1398 461-647 Sentence denotes This work was supported by the National Institute on Drug Abuse: R01 DA034231 (KFH), R01 DA044855 (KFH), R01 DA045588 (KFH), R01 DA018633 (KFH), R21 DA045630 (MM), and R01 DA045596 (SF).
T1399 649-682 Sentence denotes Compliance with Ethical Standards
T1400 684-704 Sentence denotes Conflict of Interest
T1401 705-764 Sentence denotes The authors declare that they have no conflict of interest.